Confirmed Preliminary Control Closed (unverified) Transaction verified biosolutionsCPGfood ingredientsprobiotic ingredientsprobioticsWellness

Chr. Hansen Holding acquired by Novozymes

Novozymes acquired Chr. Hansen Holding, a Denmark wellness brand, on Jan 29, 2024.

Preliminary: The announcement date, completion date, deal status, EV/revenue, EV/EBITDA, metric basis and value notes are not yet independently verified. Sources conflict on the value basis. The EV/EBITDA is outside the usual range for comps, so treat it with caution.

Transaction summary

Target
Chr. Hansen Holding
Acquirer
Novozymes
Seller
-
Announced
2022-12-12(unverified)
Geography
Denmark
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-07-26
Latest update
2026-10-29

Value and multiples

100% enterprise value

USD 12B

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

9.3x

Unverified

Period not stated

Basis: FundComb estimate

EV / EBITDA

26.2x

Unverified

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • No underlying revenue, EBITDA, or enterprise value basis was provided; multiples were preserved from the user-supplied spreadsheet without recalculation.

Source summary

Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner - GlobeNewswire

Confirmed
Open via Google News

Continue your research

Explore more comps →